Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan, Inc.    AGN

 SummaryQuotesNewsCalendarCompanyFinancials 
Company
Allergan, Inc. operates as a global healthcare company.It engages in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention,... 
Sector
Pharmaceuticals
Calendar
05/10Earnings Release
More about the company
Latest news on ALLERGAN, INC.
04/19 ALLERGAN : Novartis expands development programs for NASH through clinical colla..
04/18 ALLERGAN PLC (NYSE : AGN) Files An 8-K Other Events
04/18 ALLERGAN PLC : Other Events (form 8-K)
04/14 ALLERGAN : Exclusive New Interview Released with Allergan Global Regulatory Affa..
04/13 ALLERGAN : and Ironwood Launch Campaign Designed to Empower the Nearly 64 Millio..
04/12 ALLERGAN : New Interview Released with Allergan Global Regulatory Affairs Direct..
04/12 ALLERGAN PLC ORDINARY SHARES’ : AGN) Initiative Creating Awareness to Peo..
04/12 ALLERGAN : Introducing Juvederm Vollure® at The Choe Center
04/12 Just Three of World's Top 28 Pharmaceutical Corporations Agree to Match Pledg..
04/11 ALLERGAN : Launches Frames of Mind, Encouraging People Living with Migraine to S..
More news
Sector news : Pharmaceuticals - NEC
04/25DJSHIRE : Files 8K - Other Events
04/25DJSHIRE : Files 8K - Changes To Articles
04/25DJNasdaq Composite Tops 6000 for First Time
04/25DJASTRAZENECA : Lung Cancer Treatment Approved in EU
04/25DJELI LILLY AND : Working to Cut Costs
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
2015 MANNKIND : A Head Pain Gain Or A Pocket-Book Drain?
2015 Tracking Dan Loeb's Third Point Portfolio - Q1 2015 Update
2015 Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2015 Update
2015 Time Warner Is A Buy - Cramer's Lightning Round (5/21/15)
2015 Tracking John Paulson's Paulson & Company Portfolio - Q1 2015 Update
Advertisement
Income Statement Evolution
More Financials
Managers
NameTitle
Ambrose Robert Douglas Bailey Chief Executive Officer
Maria Teresa Hilado Chief Financial Officer
Scott M. Whitcup Chief Scientific Officer & Executive VP-Research
Raymond H. Diradoorian Executive VP-Global Technical Operations
Joann Bradley Investor Relations Contact
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ALLERGAN, INC.13.00%0
JOHNSON & JOHNSON6.67%333 142
ROCHE HOLDING LTD.8.21%220 797
PFIZER INC.3.88%200 926
NOVARTIS AG-1.08%195 490
MERCK & CO., INC.5.55%170 359
More Results